Kane Biotech Inc.
KNE.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.32M | 4.66M | 4.47M | 4.08M | 3.50M |
| Total Depreciation and Amortization | 146.20K | 152.40K | 159.20K | 156.70K | 167.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 431.40K | -7.03M | -7.01M | -6.91M | -6.51M |
| Change in Net Operating Assets | -281.20K | -832.70K | -630.50K | -617.10K | -582.70K |
| Cash from Operations | -2.02M | -3.05M | -3.01M | -3.29M | -3.43M |
| Capital Expenditure | -16.50K | -24.00K | -18.20K | -19.70K | -18.10K |
| Sale of Property, Plant, and Equipment | 6.40K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 52.00K | 7.04M | 7.04M | 6.99M | 6.99M |
| Other Investing Activities | -86.30K | -426.10K | 489.70K | 1.12M | 1.10M |
| Cash from Investing | -44.30K | 6.59M | 7.52M | 8.09M | 8.07M |
| Total Debt Issued | 1.00M | -- | -- | 0.00 | 1.00M |
| Total Debt Repaid | -576.10K | -6.62M | -6.65M | -6.65M | -6.65M |
| Issuance of Common Stock | 3.16M | 2.07M | 619.10K | 248.70K | 415.30K |
| Repurchase of Common Stock | -- | -- | -- | -16.20K | -16.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -80.10K | -1.46M | -1.65M | -1.23M | -1.25M |
| Cash from Financing | 2.50M | -4.43M | -5.62M | -5.59M | -4.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 429.10K | -887.10K | -1.12M | -790.30K | -93.30K |